152.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$152.56
Offen:
$151.9
24-Stunden-Volumen:
219.54K
Relative Volume:
0.22
Marktkapitalisierung:
$10.21B
Einnahmen:
$13.64B
Nettoeinkommen (Verlust:
$1.05B
KGV:
15.98
EPS:
9.555
Netto-Cashflow:
$1.31B
1W Leistung:
+0.14%
1M Leistung:
+9.48%
6M Leistung:
+15.30%
1J Leistung:
+0.39%
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
152.67 | 10.20B | 13.64B | 1.05B | 1.31B | 9.555 |
|
HCA
Hca Healthcare Inc
|
534.55 | 121.90B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
240.05 | 20.92B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.14 | 13.08B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
211.13 | 12.20B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
188.24 | 11.64B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc. (DVA) Receives Top Rating Amid Healthcare Sector Pressure - GuruFocus
How DaVita’s Buybacks-Driven Earnings Outlook Despite Falling Volumes Will Impact DaVita (DVA) Investors - simplywall.st
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy (DVA:NYSE) - Seeking Alpha
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
2 Warren Buffett Stocks to Buy Hand Over Fist This Month, and 1 to Avoid - The Motley Fool
DaVita Rethinks Kidney Care As Volumes Decline And Elara Stake Grows - Yahoo Finance
Reassessing DaVita (DVA) Valuation After Strong Q4 2025 Earnings Beat And Upgraded Guidance - Yahoo Finance
Neuberger Berman Group LLC Has $61.50 Million Holdings in DaVita Inc. $DVA - MarketBeat
Here's Why You Should Add DaVita Stock to Your Portfolio for Now - TradingView
DaVita Earnings Beat Resets Sentiment As Integrated Kidney Care Expands - Sahm
Is DaVita Inc. (DVA) A Good Stock To Buy? - Insider Monkey
DaVita, Inc. Hits New 52-Week High at USD 157.90 - Markets Mojo
Jim Cramer on DaVita: "Haven't Seen That Stock Do That Well In This Long" - Bitget
Jim Cramer on DaVita: “Haven’t Seen That Stock Do That Well In This Long” - Yahoo Finance
DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Teachers Retirement System of The State of Kentucky Boosts Position in DaVita Inc. $DVA - MarketBeat
TD Asset Management Inc Purchases 26,602 Shares of DaVita Inc. $DVA - MarketBeat
AustralianSuper Pty Ltd Sells 10,261 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Stock Leaps 39% In One Month, Time To Buy The Stock? - Trefis
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita, Inc. Hits New 52-Week High at USD 159.42 - Markets Mojo
DaVita Stock Analysis: A $243 per Share Valuation Model Target - TIKR.com
DaVita Inc. $DVA Shares Sold by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
DaVita Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
With DaVita Stock Surging, Have You Considered The Downside? - Trefis
DaVita at TD Cowen Conference: Strategic Growth Amid Challenges - Investing.com
Intech Investment Management Boosts DaVita Stock Holdings - National Today
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. (NYSE:DVA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amid a 64.85% Return on Equity - DirectorsTalk Interviews
Quantbot Technologies LP Has $3.88 Million Holdings in DaVita Inc. $DVA - MarketBeat
Intech Investment Management LLC Raises Stock Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVitaMeet the MentorGirls & Science - CBS News
DaVita (NYSE:DVA) Sets New 12-Month HighShould You Buy? - MarketBeat
Davita Healthcare stock hits 52-week high at 157.25 USD - Investing.com
Where Does DaVita Stock Rank Among Competitors? - Trefis
DaVita Inc.: Why This Quiet Healthcare Stock Just Got Loud for US Investors - AD HOC NEWS
DaVita’s 20-Year Fortune Streak And What It Signals For Investors - Yahoo Finance
Does DaVita Stock Lead the Pack? - Trefis
DaVita Celebrates 20 Years on Fortune's List of World's Most Admired Companies - ACCESS Newswire
Vanguard Group Inc. Trims Holdings in DaVita Inc. $DVA - MarketBeat
A Look At DaVita (DVA) Valuation After Completing Two Major Share Buyback Programs - simplywall.st
DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference - GuruFocus
DaVita, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Metrics - Markets Mojo
DaVita Stock After Earnings: Hidden Cash Machine or Value Trap? - AD HOC NEWS
Will DaVita’s (DVA) US$5.6 Billion Buybacks and Tech Push Change Its Capital Allocation Narrative - simplywall.st
DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with a Strong Return on Equity - DirectorsTalk Interviews
Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance
Is It Too Late To Consider DaVita (DVA) After Its Sharp 30 Day Surge - Yahoo Finance
DaVita Inc. (DVA): A Bull Case Theory - MSN
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):